Efficacy and Safety of the RDI Mode in Endoscopic Submucosal Dissection

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSixth Affiliated Hospital, Sun Yat-sen University

About this trial

Conventional white-light endoscopy (WLE) is hampered by insufficient contrast when attempting to identify deep vessels and active bleeding sites; visibility drops further when blood pools or spurts obscure the field, resulting in significantly lower hemostatic efficiency. Red dichromatic imaging (RDI), a novel image-enhanced endoscopic modality, has recently been shown to improve the visualization of deep-lying vessels and bleeding points, shorten hemostasis time and potentially increase overall procedural efficiency.

Although retrospective series have suggested that RDI may facilitate intra-operative bleeding control and better delineation of the submucosal plane during endoscopic submucosal dissection (ESD), high-level evidence from multicenter, randomized, controlled trials (RCTs) is lacking. No study has yet demonstrated superiority over WLE with respect to critical endpoints such as en-bloc resection rate, procedure time, complication rate and operator mental workload.

The investigators therefore designed a multicenter RCT to systematically compare the efficacy and safety of full-procedural RDI with conventional WLE during ESD.

The primary outcome parameter is the mean resection speed (mm²/min) achieved with RDI versus conventional white-light endoscopy during ESD.

The secondary outcome parameters are: complete resection (R0) rate, en-bloc resection rate, resection margin, number of intra-procedural bleeding episodes, intra-procedural blood loss, intra-procedural hemostasis time, other intra-procedural adverse events, and post-procedural adverse events.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years.

Early gastric cancer or precancerous lesions, early esophageal cancer or precancerous lesions, or early colorectal cancer/polyps that meet ESD indications.

ESD procedure to be performed at a participating center.

Lesion diameter 20-60 mm. ⑤ Written informed consent provided voluntarily.

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • RDI

    Other intervention

    Throughout the entire ESD dissection, the RDI mode is used continuously for submucosal dissection (while white-light endoscopy may be employed for observation and marking).

Treatment groups

158 Participants
are divided into 2 treatment groups
Group A: RDI groupExperimental treatment 1 intervention
Group B: WLE groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

mean resection speed (mm²/min) achieved with RDI versus conventional WLE during ESD

The resection speed is calculated as the area on the specimen-fixation board divided by the time elapsed from the first mucosal incision to complete dissection of the lesion.

Time frame
Periprocedural

Secondary outcomes

1

complete resection (R0) rate

complete resection (R0) rate

Time frame
Periprocedural
2

en-bloc resection rate

en-bloc resection rate

Time frame
Periprocedural
3

resection margin

vertical and horizontal resection margin

Time frame
Periprocedural
4

number of intra-procedural bleeding episodes

number of intra-procedural bleeding episodes

Time frame
Periprocedural

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sixth Affiliated Hospital, Sun Yat-sen University

Lead sponsor

Guangdong Provincial Hospital of Traditional Chinese Medicine

Collaborator

Guangdong Second Provincial General Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: